Evaluation of Adropin, Irisin and Cytokeratin 18 as Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Clinical Study.

EJIFCC · 2025 · PMC12743348 · PMID 41459170

Europe PMC

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The association was highly significant (p < 0.001), indicating a very high negative correlation between Adropin levels and hepatic dysfunction.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.